Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy (scientific article)

Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy is …

instance of (P31):

scholarly article

Q13442814

cites work (P2860)

Q39147132	A chemical probe toolbox for dissecting the cancer epigenome
Q30318440	Carbamate prodrug concept for hydroxamate HDAC inhibitors
Q38976490	Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation
Q46181428	Divergent JNK Phosphorylation of HDAC3 in Triple-Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity.
Q40506281	Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana).
Q92441031	In silico Design of Novel Histone Deacetylase 4 Inhibitors: Design Guidelines for Improved Binding Affinity
Q90454524	Novel histone deacetylase inhibitors bearing a 4-piperidin-4-yl-triazole scaffold as antitumor agents
Q49131145	Potent and selective HDAC6 inhibitory activity of N-(4-hydroxycarbamoylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorenes as novel sulfur analogues of Tubastatin A.
Q38246144	Selective class IIa HDAC inhibitors: myth or reality
Q39062353	Selective histone deacetylase small molecule inhibitors: recent progress and perspectives
Q26824515	Small molecule inhibitors of zinc-dependent histone deacetylases
Q39283136	The effect of various zinc binding groups on inhibition of histone deacetylases 1-11.
Q34991901	The role of small molecules in bone regeneration
Q37346960	The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity
Q36614119	Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?

P356	DOI	10.1021/JM900555U
P8608	Fatcat ID	release_5qkwwi7oe5e6dnkvx62cnmzzve
P698	PubMed publication ID	19888759
P5875	ResearchGate publication ID	38066520

P50	author	Carsten Schultz-Fademrecht	Q59564783
P2093	author name string	Philip Jones
		Christian Steinkühler
		Michael Rowley
		Ralph Laufer
		Sergio Altamura
		Ester Muraglia
		Federica Ferrigno
		Jesus M Ontoria
		Maria Cecilia Palumbi
		Rita Scarpelli
		Annalise Di Marco
		Sergio Serafini
P433	issue	21
P407	language of work or name	English	Q1860
P304	page(s)	6782-6789
P577	publication date	2009-11-01
P1433	published in	Journal of Medicinal Chemistry	Q900316
P1476	title	Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy
P478	volume	52

Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy

scientific article

Reverse relations